喀什哪家医院宫颈糜烂较好(喀什男性勃起不坚怎么回事) (今日更新中)

SANAA, Feb. 5 (Xinhua) -- The Somali pirates hijacked a Chinese-flagged commercial ship off Yemen's western city port of al- Hudaida in the Red Sea, Chinese military attache to Yemen confirmed to Xinhua on Saturday.The Chinese military confirmed that the Chinese-flagged commercial ship, which was registered in Hongkong, China, had been hijacked by the Somali pirates off the Yemeni coast, Chinese military attache to Yemen told Xinhua.The ship was then moved by the pirates towards the Somali coasts, he added, without providing how many people were on board or the date of the hijack.Earlier, Yemeni Interior Ministry said the Chinese ship called "Tien Hau" was attacked by the pirates some 11 nautical miles (20. 4 kilometers) off the Yemeni island of Al-Tair off the city port of al-Hudaida.Meanwhile, a security source at the ministry told Xinhua "the security operation room of the ministry received unconfirmed information that an anti-piracy international navy fleet might intercept the pirates and help release the Chinese ship.""We are following up the situation to confirm the release of the Chinese ship, as coast guard boats were dispatched to track the ship and pirates," he told Xinhua on condition of anonymity."The hijack took place early today, but we do not have exact information about the number of the ship's crew," he added.The Gulf of Aden is considered as one of the world's most dangerous waters because of rampant piracy.

WASHINGTON, April 6 (Xinhua) -- A study led by researchers at the University of Michigan (U-M) showed in animal studies that new cancer drug compounds they developed shrank tumors, with few side effects.The study, done in two mouse models of human cancer, looked at two compounds designed to activate a protein that kills cancer cells. The protein, p53, is inactivated in a significant number of human cancers. In some cases, it is because another protein, MDM2, binds to p53 and blocks its tumor suppresser function. This allows the tumor to grow unchecked. The new compounds block MDM2 from binding to p53, consequently activating p53."For the first time, we showed that activation of p53 by our highly potent and optimized MDM2 inhibitors can achieve complete tumor regression in a mouse model of human cancer," says lead study author Shaomeng Wang, director of the Cancer Drug Discovery Program at the U-M Comprehensive Cancer Center.Wang presented the study Wednesday at the American Association for Cancer Research 102nd annual meeting.Many traditional cancer drugs also activate p53 but they do so by causing DNA damage in both tumor cells and normal cells, causing side effects. These new MDM2 inhibitors activate p53 while avoiding the DNA damage common with other drugs. In this study, which was done in collaboration with Ascenta Therapeutics and Sanonfi-Aventis, researchers showed that these new drugs shrank tumors without significant side effects.Because p53 is involved in all types of human cancer, the new drug has potential to be used in multiple types of cancer. Further, the researchers also identified certain markers in tumors that predict which ones will be particularly sensitive to the MDM2 inhibitor, which would allow physicians to target the drug only to patients most likely to benefit.

BEIJING, March 10 (Xinhuanet) -- The price of preventing preterm labor is about to rise drastically in the U.S. next week.A drug for high-risk pregnant women costs about 10 to 20 dollars per injection. Next week, the price will shoot up to 1,500 dollars a dose, according to media reports Wednesday.This means the total cost during a pregnancy could be as much as 30,000 dollars.The massive increase comes after KV Pharmaceutical of St. Louis won an exclusive government license to produce the drug, known as Makena.The drug, a form of progesterone given as a weekly shot, has been made cheaply for years by unlicensed chemists.The March of Dimes and many obstetricians supported the move because it means quality will be more consistent and it will be easier to get, but none of them has anticipated the sharp price hike.Doctors and campaign groups have been caught out by the move, saying that the price hike may deter low-income women from getting the drug, leading to more premature births.

BEIJING, March 11(Xinhuanet)-- People with more fat around their waist, often known as “apple shape”, may not have a greater risk of heart attack than those with fatter bottoms and hips, according to a new study published in Lancet as quotted by media reports Friday.This study funded by the Medical Research Council and British Heart Foundation, reviewed 220,000 individual records from 17 countries and monitored the occurrence of heart attacks or strokes based on body mass index (BMI) versus waist-hip circumference. It found that people with "apple-shaped" obesity were at a higher risk of having heart risks compared to those with general obesity as assessed by their BMI.  This contradicts previous claims that "apple shaped" bodies were three times more likely to suffer heart attacks than those with more generally distributed fat.But experts warn obesity is still bad for the heart, no matter where the fat is, and they argue there is confusion about the best way to measure it. "Regardless of how you measure it, being obese is bad for your heart. This study suggests that measuring your waist is no better than calculating your BMI but it's not time to throw away the tape measure just yet, “Dr Mike Knapton, associate medical director at the British Heart Foundation said."We tend to underestimate our body shape and size, so measuring our waist or checking our BMI are both quick and easy ways we can check our health at home."Besides, he also listed some other heart risk factors that we need to think about too, such as blood pressure, cholesterol, diabetes and smoking.

BEIJING, March 3 (Xinhuanet) -- A new study suggested that regular use of painkiller ibuprofen may cut the risk of developing Parkinson's disease, according to Reuters reports.The research findings were published in the online edition of the journal Neurology on Wednesday and later will appear in the print edition on March 8.The study, which followed more than 136,000 U.S. men and women for six years, showed that people who took ibuprofen at least twice a week were 38 percent less likely to develop Parkinson's, a brain disorder that causes tremors and movement problems, compared to those who didn't take the pain reliever so often.Ibuprofen is sold in the U.S. as a non-steroidal anti-inflammatory drug (NSAID). But the study didn't prove that other NSAIDS, like aspirin or naproxen, could also cut the Parkinson's risk."Our study suggests ibuprofen could be a potential neuroprotective agent against Parkinson's," says lead researcher Dr. Xiang Gao from Harvard Medical School, "Protective effects are seen after taking ibuprofen two or more times a week. That's so-called regular use."However, he also warned that no proof has been found that ibuprofen itself can help ward off Parkinson's, and said that it's too early to recommend people to start taking ibuprofen to protect against the disorder.Gao said, "We just see an association, not some causal relationship."Besides, regular ibuprofen use has risks, like stomach bleeding and kidney damage.

来源：资阳报